Listed

Eledon Pharmaceuticals, Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 10, 2015 and accepted by EDGAR at Nov 10, 2015, 07:44 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$0us-gaap:SalesRevenueGoodsNet
Revenue9 months2015-01-01 to 2015-09-30$0us-gaap:SalesRevenueGoodsNet
Research and development3 months2015-07-01 to 2015-09-30$8.5mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$24.9mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-07-01 to 2015-09-30−$11.9mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$34.2mus-gaap:OperatingIncomeLoss
Income tax9 months2015-01-01 to 2015-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-07-01 to 2015-09-30−$11.9mus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$34.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.53us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$1.52us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2015-01-01 to 2015-09-30−$32.4mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2015-01-01 to 2015-09-30$349.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-09-30$33.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$76.9mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$77.6mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$5.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$5.7mus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$71.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-15-372762. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.